English
Back
Download
Log in to access Online Inquiry
Back to the Top

$CNS Pharmaceuticals (CNSP.US)$ “Key financial metrics from ...

“Key financial metrics from the report indicate that CNS Pharmaceuticals significantly increased its cash and cash equivalents to over $6.9 million from $548,721 at the end of 2023.”
*nfa
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
+0
Translate
Report
6213 Views
Comment
Sign in to post a comment
    Idealist champion 。* ҉* ੈ‧₊ 。゚not financial advice
    362
    Followers
    84
    Following
    3307
    Visitors
    Follow

    Market Insights

    Market Hot Picks Market Hot Picks
    Unlock Now

    Reassessing Chinese Assets

    Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.